Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Schiff

Showing results (51-60 of 80) with videos related to

Pageof 8
Sort By:
Annals of the Rheumatic Diseases|January 7, 2006
Safety of extended treatment with anakinra in patients with rheumatoid arthritisR M Fleischmann, J Tesser, M H Schiff, et al.
Annals of the Rheumatic Diseases|February 28, 2018
Efficacy and safety of monotherapy with sirukumab compared with adalimumab monotherapy in biologic-naïve patients with active rheumatoid arthritis (SIRROUND-H): a randomised, double-blind, parallel-group, multinational, 52-week, phase 3 studyPeter C Taylor, Michael H Schiff, Qingmin Wang, et al.
Drugs & Aging|March 16, 2006
Long-term experience with etanercept in the treatment of rheumatoid arthritis in elderly and younger patients: patient-reported outcomes from multiple controlled and open-label extension studiesMichael H Schiff, Elaine B Yu, Michael E Weinblatt, et al.
The Journal of Rheumatology|March 17, 2006
Etanercept treatment in adults with established rheumatoid arthritis: 7 years of clinical experienceLarry W Moreland, Michael E Weinblatt, Edward C Keystone, et al.
The Journal of Rheumatology. Supplement|February 6, 2009
Unresolved issues in identifying and overcoming inadequate response in rheumatoid arthritis: weighing the evidenceStanley B Cohen, Marc D Cohen, John J Cush, et al.
Current Medical Research and Opinion|January 6, 2006
Real-world effectiveness of select biologic and DMARD monotherapy and combination therapy in the treatment of rheumatoid arthritis: results from the RADIUS observational registryArthur L Weaver, Richard L Lautzenheiser, Michael H Schiff, et al.
Anaesthesia|August 23, 2008
The Heidelberg Peri-anaesthetic Questionnaire--development of a new refined psychometric questionnaireJ H Schiff, A S Fornaschon, S Frankenhauser, et al.
The Journal of Rheumatology|April 3, 2003
Response to etanercept (Enbrel) in elderly patients with rheumatoid arthritis: a retrospective analysis of clinical trial resultsRoy M Fleischmann, Scott W Baumgartner, Elizabeth A Tindall, et al.
Minerva Anestesiologica|July 9, 2010
The Anesthesia Preoperative Evaluation Clinic (APEC): a prospective randomized controlled trial assessing impact on consultation time, direct costs, patient education and satisfaction with anesthesia careJ H Schiff, S Frankenhauser, M Pritsch, et al.
Annals of the Rheumatic Diseases|December 7, 2007
Adalimumab effectively reduces the signs and symptoms of active ankylosing spondylitis in patients with total spinal ankylosisD van der Heijde, A L Pangan, M H Schiff, et al.
Pageof 8

Showing results (51-60 of 80) with videos related to

Sort By:
Pageof 8
Annals of the Rheumatic Diseases|January 7, 2006
Safety of extended treatment with anakinra in patients with rheumatoid arthritisR M Fleischmann, J Tesser, M H Schiff, et al.
Annals of the Rheumatic Diseases|February 28, 2018
Efficacy and safety of monotherapy with sirukumab compared with adalimumab monotherapy in biologic-naïve patients with active rheumatoid arthritis (SIRROUND-H): a randomised, double-blind, parallel-group, multinational, 52-week, phase 3 studyPeter C Taylor, Michael H Schiff, Qingmin Wang, et al.
Drugs & Aging|March 16, 2006
Long-term experience with etanercept in the treatment of rheumatoid arthritis in elderly and younger patients: patient-reported outcomes from multiple controlled and open-label extension studiesMichael H Schiff, Elaine B Yu, Michael E Weinblatt, et al.
The Journal of Rheumatology|March 17, 2006
Etanercept treatment in adults with established rheumatoid arthritis: 7 years of clinical experienceLarry W Moreland, Michael E Weinblatt, Edward C Keystone, et al.
The Journal of Rheumatology. Supplement|February 6, 2009
Unresolved issues in identifying and overcoming inadequate response in rheumatoid arthritis: weighing the evidenceStanley B Cohen, Marc D Cohen, John J Cush, et al.
Current Medical Research and Opinion|January 6, 2006
Real-world effectiveness of select biologic and DMARD monotherapy and combination therapy in the treatment of rheumatoid arthritis: results from the RADIUS observational registryArthur L Weaver, Richard L Lautzenheiser, Michael H Schiff, et al.
Anaesthesia|August 23, 2008
The Heidelberg Peri-anaesthetic Questionnaire--development of a new refined psychometric questionnaireJ H Schiff, A S Fornaschon, S Frankenhauser, et al.
The Journal of Rheumatology|April 3, 2003
Response to etanercept (Enbrel) in elderly patients with rheumatoid arthritis: a retrospective analysis of clinical trial resultsRoy M Fleischmann, Scott W Baumgartner, Elizabeth A Tindall, et al.
Minerva Anestesiologica|July 9, 2010
The Anesthesia Preoperative Evaluation Clinic (APEC): a prospective randomized controlled trial assessing impact on consultation time, direct costs, patient education and satisfaction with anesthesia careJ H Schiff, S Frankenhauser, M Pritsch, et al.
Annals of the Rheumatic Diseases|December 7, 2007
Adalimumab effectively reduces the signs and symptoms of active ankylosing spondylitis in patients with total spinal ankylosisD van der Heijde, A L Pangan, M H Schiff, et al.
Pageof 8